China: Food & Beverage Sirio Pharma Launches Multimillion Gummy Production Plant
The 26,000 sq m gummy production plant will form a part of the ‘Centre of Excellence’ wherein the plant will produce up to 2.4 billion gummies per year. With this project, the company aims at attracting business from global markets.
Shantou/China – Sirio Pharma Co. (Sirio) – the global nutraceutical contract development and manufacturing organisation (CDMO) – has recently announced the opening of a gummy production plant at its new development and manufacturing facility in Ma’anshan (300 km West of Shanghai, China). This announcement comes 11 years after Sirio opened its first gummy facility. The new site will be built in several phases and form a ‘Centre of Excellence’ covering an enormous 240,000 sq m.
Phase I of the site’s construction has just been completed and features a 26,000 sq m gummy production plant and its associated building has been designed to expedite development and manufacturing of gummy formulations for global customers.
The gummy production plant features integrated R&D and will increase production capacity to 2.4 billion gummies per year. Sirio also expanded its ability to make innovative products such as liquid filled, centre-filled, swirled and multi-coloured gummies. In addition, Sirio has hundreds of standard gummy formulation options suitable for market launch in the US and EU, and vegetarian options including carrageen and pectin, as well as sugar free and low-sugar options.
The company is predicting that its market share for contract services in the United States and Europe will rapidly increase.